AaronsonN.K., BakkerW., StewartA.L., van DamF.S.A.M., van ZandwijkN., YarnoldJ.R., KirkpatrickA.: A multidimensional approach to the measurement of quality of life in lung cancer clinical trials. In: The Quality of Life of Cancer Patients, AaronsonN.K., BeckmannJ.H. (Eds.), pp. 63–82, Raven Press, New York, 1987.
2.
AaronsonN.K., BullingherM., AhmedzaiS.: A modular approach to quality of life assessment in cancer clinical trials. Recent Results Cancer Res., 111: 231–249, 1988.
3.
BeckA.T., WardC.H., MendelsohnM., MockJ., ErbaughJ.: An inventory for measuring depression. Arch. Gen. Psychiat., 4: 561–571, 1961.
4.
BergnerM., BobbittR., PollardW.E.: The Sickness Impact Profile: validation of a health status measure. Med. Care, 14: 57–67, 1976.
5.
DautR.L., CleelandC.S., FlaneryR.C.: Development of the Winsconsin Brief Pain Questionnaire to assess pain in cancer and other diseases. Pain, 17: 197–210, 1983.
6.
de HaesJ.C.J.M., van KnippenbergF.C.E., NeijtJ.P.: Measuring psychological and physical distress in cancer patients: structure and application of the Rotterdam Symptom Checklist. Br. J. Cancer, 62: 1034–1038, 1990.
DerogatisL.R., SpencerP.M.: The Brief Symptom Inventory (BSI). Administration, scoring and procedures manual-I.Clinical Psychometric Res., Baltimore, MD, 1982.
9.
FolsteinM.F., FettingJ.H., LoboA., NiazU., CapozzoliK.D.: Cognitive assessment of cancer patients. Cancer, 53 (suppl.): 2250–2255, 1984.
10.
FolsteinM.F., FolsteinS.E., McHughP.R.: Mini Mental State. A practical guide for grading the cognitive state of patients for the clinician. J. Psychiatry Res., 12: 189–198, 1975.
11.
GelberR.D., GoldhirschA.: A new endpoint for the assessment of adjuvant therapy in postmenopausal women with operable breast cancer. J. Clin. Oncol., 4: 1772–1779, 1986.
12.
HamiltonM.: A rating scale for depression. J. Neurol. Neurosurg. Psychiat., 23: 56–62, 1960.
13.
HathawayS., McKinleyC.: Minnesota Multiphasic Personality Inventory, Psychological Corporation, New York, 1951.
14.
HuntS., McEwenJ., McKennaS.: Measuring health status.Croom Helm, London, 1986.
15.
HuskissonE.C.: Measurement of pain. Lancet, 2: 1127, 1974.
16.
JacobsJ.W., BernhardM.R., DelgadoA., StrainJ.J.: Screening for organic mental syndromes in the medically ill. Ann. Intern. Med., 86: 40–46, 1977.
17.
KarnofskyD.A., AbelmannW.H., CraverL.F., BurchenalJ.H.: The use of nitrogen mustards in the palliative treatment of carcinoma. Cancer, 1: 634–656, 1948.
18.
KarnofskyD.A., BurchenalJ.H.: The clinical evaluation of chemotherapeutic agents in cancer. In: Evaluation of Chemotherapeutic Agents.MacLeodC.M. (Ed.), pp. 191–205, Columbia University Press, New York, 1949.
19.
KatzS., FordA., MoskowitsR.W.: Studies of illness in the aged: the index of ADL: a standardized measure of biological and psychosocial function. JAMA, 185: 914–919, 1963.
20.
KatzS.: Multidisciplinary study of illness in aged persons: VI. Comparison study of rehabilitated and nonrehabilitated patients with fracture of the hip. J. Chron. Dis., 15: 979–984, 1962.
LevineP.M., GuyattG.H., GentM., De PauwS., GoodyearM.D., HryniukW.M., ArnoldA., FindlayB., SkillingsJ.R., BramwellV.H., LevinL., BushH., Abu-ZahraH., KotalikJ.: Quality of life in stage II breast cancer; an instrument for clinical trials. J. Clin. Oncol., 6: 1798–1810, 1988.
24.
MaguireP., SelbyP.: Assessing quality of life in cancer patients. Br. J. Cancer, 60: 437–440, 1989.
25.
McCorkleR., YoungK.: Development of a symptom distress scale. Cancer Nurs., 1: 373–378, 1978.
26.
McMillen MoinpourC., FeiglP., MetchB., HaydenK.A., MeyskensF.L., CrowleyJ.: Quality of life end points in cancer clinical trials: review and recommendations. JNCI, 81: 485–495, 1989.
27.
McNairD.M., LorrM., DropplemanL.F.: EITS Manual for the Profile of Mood States.Educational and Industrial Testing Service, San Diego CA, 1971.
28.
MelzackR.: The short-form McGill Pain Questionnaire. Pain, 30: 191–197, 1987.
29.
MorrowG.R.: The assessment of nausea and vomiting. Past problems, current issues, and suggestions for future research. Cancer, 15 (suppl.): 2267–2280, 1984.
30.
OxmanT.E., SchnurrP.P., SilberfarbP.M.: Assessment of cognitive function in cancer patients. Hospice J., 3: 99–117, 1986.
31.
PriestmanT.J., BaumM.: Evaluation of quality of life in patients receiving treatment for advanced breast cancer. Lancet, 1: 899–901, 1976.
32.
SchipperH., ClinchJ., McMurrayA., LevittM.: Measuring the quality of life of cancer patients: the functional living index-cancer: development and validation. J. Clin. Oncol., 2: 472–483, 1984.
33.
ScottJ., HuskissonE.C.: Graphic representation of pain. Pain, 2: 175–184, 1976.
34.
SelbyP.J., ChapmanJ.A., Etazadi-TamoliJ., DalleyD., BoydN.E.: The development of a method for assessing the quality of life of cancer patients. Br. J. Cancer, 50: 13–22, 1984.
35.
SpielbergerC.D.: Manual for the State-Trait Anxiety Inventory (Form Y).Consulting Psychologists Press, Palo Alto, CA, 1983.
36.
SpitzerO.W., DobsonA.J., HallJ., ChestermanE., LeviJ., SheperdR., BattistaR.N., CatchloveB.R.: Measuring the quality of life of cancer patients. A concise QL-Index for use by physicians. J. Chron. Dis., 34: 585–597, 1981.
37.
TamburiniM., SelmiS., De ConnoF., VentafriddaV.: Semantic descriptors of pain. Pain, 25: 187–193, 1987.
38.
VentafriddaV., van DamF.S.A.M., YancikR., TamburiniM. (Eds.): Assessment of quality of life and cancer treatment.Elsevier, Excerpta Medica, Amsterdam, 1986.
39.
VentafriddaV., De ConnoF., Di TrapaniP., GallicoS., GuariseG., RigamontiG., TamburiniM.: A new method of quantification based on weekly self-descriptive record of the intensity and duration of pain. In: Advances in Pain Research and Therapy, BonicaJ.J., LindblomU., IggoA. (Eds.), vol. 5, pp. 891–895, Raven Press, New York, 1983.
40.
ZubrodC.G., SchneidermanM., FreiE.: Appraisal of methods for the study of chemotherapy of cancer in man: comparative therapeutic trial of nitrogen mustard and triethylene thiophosphoramide. J. Chron. Dis., 11: 7–33, 1960.
41.
ZungW.W.: Self-rating depression scale in an outpatient clinic. Arch. Gen. Psychiat., 13: 508–515, 1965.
42.
ZungW.W.: A rating instrument for anxiety disorders. Psychosom., 12: 371–379, 1971.